|
The CBD’s Subsidiary Body on Scientific, Technical and Technological advice is currently holding a virtual informal session (17-19 and 24-26 February 2021). Among the agenda items discussed were that of synthetic biology, and risk assessment and risk management of LMOs. The issue of gene drive organisms features prominently in both these agenda items, with civil society calling for a moratorium on environmental releases of such organisms. […]
Parties to the CBD have approved conflicts of interest procedures to limit the influence of private sector industry and other economic and vested interests from unduly influencing decisions taken to protect biological diversity. […]
Parties to the CBD have concluded that the rapid and fast-paced developments in the field of synthetic biology and their potential adverse effects need to be anticipated, monitored and assessed. […]
Parties to the Cartagena Protocol on Biosafety, at a subsidiary meeting in Montreal, have breathed some life back into the risk assessment work that is critical to the implementation of the Protocol. […]
Further work on biosafety risk assessment which is a key pillar under the Cartagena Protocol on Biosafety has received a setback at the UN Biodiversity Conference […]
The report of the recent Scientific Conference, Taking Stock – 20 years of GM crops – 40 years of ‘genetic engineering’, which was held in Mexico City, 1-2 December 2016. […]
At the meeting of the Cartagena Protocol on Biosafety in Cancun, Mexico, the continued work on risk assessment under the Protocol is under threat. […]
The issue of synthetic biology, which cross cuts the Convention on Biological Diversity, Cartagena Protocol on Biosafety and Nagoya Protocol on Access and Benefit-Sharing, will be among the most hotly debated issue at the UN Biodiversity Conference meeting from 4-17 December in Cancún, Mexico. […]
A wide spectrum of 160 civil society organisations and networks have called for a global moratorium on the controversial genetic extinction technology known as “gene drives”. […]
The issue of synthetic biology, which cross cuts the Convention on Biological Diversity, Cartagena Protocol on Biosafety and Nagoya Protocol on Access and Benefit-Sharing, will be among the most hotly debated issue at the UN Biodiversity Conference. […]
|
|